Big Tech stock performance stories

Jul 27, 2026

Sarepta Therapeutics appoints Michael Severino as new CEO

Sarepta Therapeutics named former AbbVie executive Michael Severino as its new chief executive officer as the company seeks to recover from declining share prices and faces looming competition in its rare disease drug portfolio.

Jul 27, 20262 sources

May 7, 2026

Novo Nordisk Reports Positive Earnings on Oral Wegovy Development Progress

Novo Nordisk's stock price and earnings received a boost following less-negative news about the development of an oral version of its blockbuster weight loss drug Wegovy, marking progress in the company's efforts to create a pill formulation.

May 7, 20261 source